“…Patients are commonly treated empirically, exposed to a broad spectrum of different antibiotics in severe cases, thus increasing the chances of antibiotic resistance development. , New methods and technologies for AST, aiming to overcome these significant drawbacks, are under constant development, including genome sequencing, , mass spectrometry, , surface enhanced Raman scattering (SERS), , Fourier transform infrared spectroscopy (FTIR), and infrared microscopy. , The aforementioned methods depend on laboratory-based analytical techniques that require expensive and bulky equipment, increasing the cost of the test. , In addition, the detection of a resistance gene or mutation often does not necessarily correlate with resistance, as the presence of specific resistance genes does not directly imply its active expression. , Because of advantages such as high sensitivity, cost-effectiveness, portable instrumentation, and short analysis time, electroanalytical methods emerged as attractive approaches to detect bacterial drug resistance over the last two decades. , These methods allow direct measurements in complex biological samples, such as urine and blood, making them promising tools for the development of sensors for the point-of-care detection of antibiotic resistance . Studies employing electrochemical techniques to detect bacterial antibiotic susceptibility have been reported, including those for Staphylococcus aureus, Mycobacterium smegmatis, Klebsiella pneumoniae, Salmonella gallinarum, and Escherichia coli strains. Although these studies report successful methodologies to detect antibiotic resistance, the described systems are not user-friendly enough to find broad application in clinical settings, as they involve complex electrode surface modification steps, which often limits sensor stability and storage in addition to increasing production costs.…”